Al's Comment:

 Early results were very impressive.  This is a different type of immunotherapy that does not depend on the body creating antibodies.  It is an old treatment that was hampered in the past by an inability to get the drug where it is needed.  With modern equipment, it is now possible to get it exactly where it is needed and it should do a lot better. I will be keeping an eye on this trial!

Disclosure: This company is a sponsor of our organization.


Posted on: 03/17/2017

Medicenna BioPharma Announces Strategic Collaboration with MD Anderson Cancer Center to Advance Next Generation Empowered Cytokines™

 


Click HERE to return to brain tumor news headlines.


Our privacy / cookie policy has changed.
Click HERE to read it!